Dyne Therapeutics, Inc. - 8-K Filing
Dyne Therapeutics elected Barry E. Greene as a Class I director on June 22, 2026, to serve until the 2027 Annual Meeting of Stockholders or his earlier resignation or removal. Mr. Greene received an option to purchase 57,463 shares at $20.87 per share under the company’s 2020 Stock Incentive Plan and will receive annual cash compensation of $45,000. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)
Tickers: $DYN